Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Cvrx Inc (CVRX)

Cvrx Inc (CVRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
CVRx to Present at Canaccord Genuity's 46th Annual Growth Conference GlobeNewswire - Tue Jul 28, 7:30AM CDT

MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...

CVRX : 5.18 (-3.81%)
CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026 GlobeNewswire - Thu Jul 23, 3:30PM CDT

MINNEAPOLIS, July 23, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...

CVRX : 5.18 (-3.81%)
CVRx Announces Chief Financial Officer Transition GlobeNewswire - Tue Jun 9, 6:30AM CDT

MINNEAPOLIS, June 09, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...

CVRX : 5.18 (-3.81%)
CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference GlobeNewswire - Wed May 27, 3:30PM CDT

MINNEAPOLIS, May 27, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...

CVRX : 5.18 (-3.81%)
CVRx to Present at the William Blair 46th Annual Growth Stock Conference GlobeNewswire - Wed May 20, 3:30PM CDT

MINNEAPOLIS, May 20, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...

CVRX : 5.18 (-3.81%)
CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy GlobeNewswire - Thu May 14, 7:00AM CDT

MINNEAPOLIS, May 14, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...

CVRX : 5.18 (-3.81%)
MarketBeat.com
CVRx Q1 Earnings Call Highlights MarketBeat - Mon May 11, 6:05PM CDT

CVRx (NASDAQ:CVRX) reported first-quarter 2026 revenue of $14.8 million, up 20% from the prior-year period, as U.S. growth in its Barostim heart failure business helped the company exceed the high end...

CVRX : 5.18 (-3.81%)
CVRx: Q1 Earnings Snapshot AP - Mon May 11, 3:50PM CDT

CVRx: Q1 Earnings Snapshot

CVRX : 5.18 (-3.81%)
CVRx Reports First Quarter 2026 Financial and Operating Results GlobeNewswire - Mon May 11, 3:05PM CDT

MINNEAPOLIS, May 11, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...

CVRX : 5.18 (-3.81%)
CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population GlobeNewswire - Mon May 4, 3:30PM CDT

MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients...

CVRX : 5.18 (-3.81%)

Barchart Exclusives

Meta’s Cash Engine Is Still Running Hot, Strengthening the Bull Thesis Barchart - Sat Aug 1, 2:30PM CDT
Meta's Family of Apps generated $59.4 billion in advertising revenue during the second quarter, up 27% year-over-year. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.